Supplementary Methods, Figures 1 - 3, Tables 1 - 2 from A Recombinant Modified Vaccinia Ankara Vaccine Encoding Epstein–Barr Virus (EBV) Target Antigens: A Phase I Trial in UK Patients with EBV-Positive Cancer

Autor: Neil M. Steven, Alan B. Rickinson, Anthony T. C. Chan, Edwin P. Hui, Steve Wilson, Andrew Hartley, Lesley McGuigan, Ceri Edwards, Claudia Roberts, Jen Matthews, Manjit Tanday, David A. Price, Kristin Ladell, James Turner, Lip Wai Lee, Kevin Harrington, Hui Jia, Graham S. Taylor

Additional detail of materials and methods used. Figure 1. Flow chart detailing dose escalation schema. Figure 2. MVA-EBNA1/LMP2 Vaccination does not alter broad subsets of immune cells. Figure 3. EBNA1 antibody response before and after MVA-EL vacci

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac23961963214984f8aa7aeec4fdeb5e
https://doi.org/10.1158/1078-0432.22459926.v1

Temporal and Concentration Effects of Methanol on Cryopreservation of Zebrafish (Danio rerio) Sperm

Autor: Terrence R. Tiersch, E Hu, Jen Matthews, Zoltán M. Varga, Huiping Yang, Carrie Carmichael

Publikováno v: Zebrafish. 17:233-242

We evaluated the cryoprotective effects of methanol on zebrafish sperm at different concentrations, exposure times, and stages during cryopreservation. Samples were collected by crushing of dissect...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e4c29d4084211eaf4b282808a215fcc2
https://doi.org/10.1089/zeb.2019.1849

A Recombinant Modified Vaccinia Ankara Vaccine Encoding Epstein–Barr Virus (EBV) Target Antigens: A Phase I Trial in UK Patients with EBV-Positive Cancer

Autor: Hui Jia, Anthony T.C. Chan, David Price, Kevin J. Harrington, Lip Wai Lee, Graham S. Taylor, James E. Turner, Alan B. Rickinson, Lesley McGuigan, Edwin P. Hui, Jen Matthews, Neil Steven, Kristin Ladell, Andrew Hartley, Manjit Tanday, Ceri Edwards, Steve Wilson, Claudia Roberts

Publikováno v: Taylor, G S, Jia, H, Harrington, K, Lee, L W, Turner, J E, Ladell, K, Price, D A, Tanday, M, Matthews, J, Roberts, C, Edwards, C, McGuigan, L, Hartley, A, Wilson, S, Hui, E P, Chan, A T C, Rickinson, A B & Steven, N M 2014, ' A recombinant modified vaccinia Ankara vaccine encoding Epstein-Barr virus (EBV) target antigens : a phase I trial in UK patients with EBV-positive cancer ', Clinical Cancer Research, vol. 20, no. 19, pp. 5009-5022 . https://doi.org/10.1158/1078-0432.CCR-14-1122-T

Purpose: Epstein–Barr virus (EBV) is associated with several cancers in which the tumor cells express EBV antigens EBNA1 and LMP2. A therapeutic vaccine comprising a recombinant vaccinia virus, MVA-EL, was designed to boost immunity to these tumor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64a07a9a65ef718f19acf29b8679bc1c
https://doi.org/10.1158/1078-0432.ccr-14-1122-t